sulfinpyrazone has been researched along with Kidney Papillary Necrosis in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Kidney Papillary Necrosis: A complication of kidney diseases characterized by cell death involving KIDNEY PAPILLA in the KIDNEY MEDULLA. Damages to this area may hinder the kidney to concentrate urine resulting in POLYURIA. Sloughed off necrotic tissue may block KIDNEY PELVIS or URETER. Necrosis of multiple renal papillae can lead to KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wyllie, RG | 1 |
| Hill, GS | 1 |
| Murray, G | 1 |
| Ramsden, PW | 1 |
| Heptinstall, RH | 1 |
1 other study available for sulfinpyrazone and Kidney Papillary Necrosis
| Article | Year |
|---|---|
Experimental papillary necrosis of the kidney. 3. Effects of reserpine and other pharmacologic agents on the lesion.
Topics: Adenosine Triphosphatases; Animals; Blood Pressure; Bromine; Catecholamines; Chlorpromazine; Colorin | 1972 |